Orbsen Therapeutics

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

Orbsen Therapeutics company profile

Orbsen Therapeutics Limited is a leading company in the development of regenerative medicine therapies across a range of diseases and medical conditions. Formed in 2006 as a spin out from Ireland’s Regenerative Medicine Institute (REMEDI), Orbsen has since developed proprietary technologies focused on the isolation of pure and defined stromal cells. Headed by some of the world’s most prominent scientists in the field of regenerative medicine, Orbsen Therapeutics is headquartered on campus at NUI Galway, operating out of the Orbsen Building, which also houses REMEDI’s state-of-the-art GMP facility. Their offices have beautiful views overlooking Lough Corrib, which in ancient times was called Lough Orbsen, thus their company name.

Business identity

Contact email
[email protected]
Phone number
+353 0 91 528778
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2006-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$1.3M
Last funding
Series Unknown / $1.3M / 2017-07-26
Last equity funding
Series Unknown / $1.3M
Founders
2
Articles
10

Founders and investors

Founders

Larry CoutureStephen Elliman